毛螺菌科
肠道菌群
阿克曼西亚
褐色脂肪组织
内科学
丁酸盐
肥胖
减肥
微生物群
生物
丙酸盐
内分泌学
生理学
医学
免疫学
厚壁菌
生物信息学
生物化学
乳酸菌
基因
发酵
16S核糖体RNA
作者
Carsten T. Herz,Oana C. Kulterer,Marlene Prager,Rodrig Marculescu,Gerhard Prager,Alexandra Kautzky‐Willer,Marcus Hacker,Slave Trajanoski,Harald Köfeler,Birgit Gallé,Alexander Haug,David Berry,Florian W. Kiefer
标识
DOI:10.1093/ejendo/lvaf081
摘要
Abstract Objective The mechanisms of bariatric surgery-induced weight loss and metabolic improvements are still incompletely understood and reach beyond malabsorption or calorie restriction. We sought to investigate the effect of bariatric surgery on brown adipose tissue (BAT) activity and a potential connection with changes in energy metabolism, the gut microbiota, and short-chain fatty acid (SCFA) composition. Methods We included 32 subjects (25 females) with morbid obesity and analyzed their metabolic profile, gut microbiota composition, circulating SCFAs, energy expenditure, and cold-induced BAT activity using [18F]Fluorodeoxyglucose-positron emission tomography–computed tomography before and up to 1 year after bariatric surgery. Results Twelve months after surgery, the percentage of individuals with active BAT had increased from 28% to 53%. The BAT-negative (BATneg) individuals who had an adverse metabolic profile at baseline compared with subjects with active BAT (BATpos) showed a greater metabolic benefit after surgery. While no changes in overall gut bacterial diversity were observed between BATpos and BATneg, the abundance of 3 specific bacterial families, including Akkermansiaceae, Pasteurellaceae, and Carnobacteriaceae, was distinctly regulated between BAT groups. The bacterial genera most strongly increased in BATpos vs BATneg subjects were all positively correlated with BAT volume and BAT activity. Finally, circulating concentrations of the SCFAs acetate, butyrate, and propionate rose after bariatric surgery and were related to bacterial genera such as Akkermansia, Dialister, and Lachnospiraceae FCS020 group, all known SCFA producers. Conclusions Bariatric surgery helps recruit active BAT in individuals with obesity and is linked to distinct alterations in the gut microbiome and SCFA composition. Trial registration number ClinicalTrials.gov (NCT03168009).
科研通智能强力驱动
Strongly Powered by AbleSci AI